te list of side effects of ATRIPLA and all the medicines you will take.
How do I store ATRIPLA?
Keep ATRIPLA and all other medicines out of reach of children.
Store ATRIPLA at room temperature 77 °F (25 °C).
Keep ATRIPLA in its original container and keep the container tightly closed.
Do not keep medicine that is out of date or that you no longer need. If you throw any medicines away make sure that children will not find them.
General information about ATRIPLA:
Medicines are sometimes prescribed for conditions that are not mentioned in patient information leaflets. Do not use ATRIPLA for a condition for which it was not prescribed. Do not give ATRIPLA to other people, even if they have the same symptoms you have. It may harm them.
This leaflet summarizes the most important information about ATRIPLA. If you would like more information, talk with your healthcare provider. You can ask your healthcare provider or pharmacist for information about ATRIPLA that is written for health professionals.
Do not use ATRIPLA if the seal over bottle opening is broken or missing.
What are the ingredients of ATRIPLA?
Active Ingredients: efavirenz, emtricitabine, and tenofovir disoproxil fumarate
Inactive Ingredients: croscarmellose sodium, hydroxypropyl cellulose, microcrystalline cellulose, magnesium stearate, sodium lauryl sulfate. The film coating contains black iron oxide, polyethylene glycol, polyvinyl alcohol, red iron oxide, talc, and titanium dioxide.
SPL UNCLASSIFIED
June 2012
ATRIPLA is a trademark of Bristol-Myers Squibb & Gilead Sciences, LLC. COMPLERA, EMTRIVA, HEPSERA, TRUVADA, and VIREAD are trademarks of Gilead Sciences, Inc. SUSTIVA is a trademark of Bristol-Myers Squibb Pharma Company. Reyataz and Videx are trademarks of Bristol-Myers Squibb Company. Pravachol is a trademark of ER Squibb & Sons, LLC. Other brands listed are the trademarks of their respective owners.
21-937-GS-010
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION
DRUG: Atripla
GENERIC: efavirenz, emtricitabine, and tenofovir disoproxil fumarate
DOSAGE: TABLET, FILM COATED
ADMINSTRATION: ORAL
NDC: 24236-292-22
STRENGTH:600 mg
COLOR: pink
SHAPE: OVAL
SCORE: No score
SIZE: 20 mm
IMPRINT: 150
QTY: 150
Close
INGREDIENTS AND APPEARANCE
ATRIPLA
efavirenz, emtricitabine, and tenofovir disoproxil fumarate tablet, film coated
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:24236-292(NDC:15584-0101)
Route of Administration ORAL
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
EFAVIRENZ (UNII: JE6H2O27P8) (EFAVIRENZ - UNII:JE6H2O27P8) EFAVIRENZ 600 mg
Inactive Ingredients
Ingredient Name Strength
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
HYDROXYPROPYL CELLULOSE (TYPE H) (UNII: RFW2ET671P)
MAGNESIUM STEARATE (UNII: 70097M6I30)
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
SODIUM LAURYL SULFATE (UNII: 368GB5141J)
FERROSOFERRIC OXIDE (UNII: XM0M87F357)
POLYETHYLENE GLYCOL 3350 (UNII: G2M7P15E5P)
POLYVINYL ALCOHOL (UNII: 532B59J990)
FERRIC OXIDE RED (UNII: 1K09F3G675)
TALC (UNII: 7SEV7J4R1U)
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
Product Characteristics
Color pink |
